Spectrum Pharmaceuticals (SPPI) Stock Highlights

1.03 | +0%

2023-09-07 16:06:08

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are its current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor (G-CSF) for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer (NSCLC) tumors with various mutations.

Statistics

Range Today

1.03 1.03

Volume Today 0

Range 1 Year

0.32 1.57

Volume 1 Year 659.83M

Range 3 Year

0.32 5.24

Volume 3 Year 2.15B

Range 10 Year

0.32 25.29

Volume 10 Year 4.2B

Highlights

Market Capitalization 211.4M (small)

Current Price 1.03

Performance

Latest 0%

1 Month +6.19%

3 Months -3.74%

6 Months +27.16%

1 Year +9.57%

3 Years -70.06%

5 Years -95.01%

10 Years -87.81%

Benchmarks

Market Capitalization

221 / 368

Gross Profits

102 / 278

Total Revenue

0 / 300

Total Rank

265 / 368

Free Cashflow

0 / 352

Performance 5 years

311 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.